The modulation of sensorimotor gating deficits by mesolimbic cholecystokinin

Neuroscience Letters

Volumn 229, Issue 1, 1997, Pages 5-8

  Feifel, David ^a   Swerdlow, Neal R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apomorphine; Cholecystokinin; Dopamine; Prepulse inhibition; Schizophrenia; Sensorimotor gating; Startle

Indexed keywords

APOMORPHINE; CHOLECYSTOKININ; CHOLECYSTOKININ OCTAPEPTIDE; DOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY STIMULATION; CONTROLLED STUDY; INTRACEREBRAL DRUG ADMINISTRATION; LIMBIC CORTEX; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SENSORIMOTOR FUNCTION; STARTLE REFLEX;

ACOUSTIC STIMULATION; ANIMALS; APOMORPHINE; CHOLECYSTOKININ; DOPAMINE AGONISTS; INJECTIONS; LIMBIC SYSTEM; MALE; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR; STARTLE REACTION;

EID: 0030748438     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00409-6     Document Type: Article

References (16)

1. Albus, M., Cholecystokinin, Prog. Neuropsychopharmacol. Biol. Psychiatry, 12 (Suppl.)(1988) S5-21.
2. Braff, D.L. and Geyer, M.A., Sensorimotor gating and schizophrenia: human and animal model studies, Arch. Gen. Psychiatry, 47 (1990) 181-188.
3. Branchereau, P., Champagna, J., Roques, B.P. and Denavit-Saubie, M., CCK modulates inhibitory synaptic transmission in the solitary complex through CCK-B sites, NeuroReport, 3 (1992) 909-912.
4. Crawley, J.N., Attenuation of dark-induced hyperlocomotion by a cholecystokinin antagonist in the nucleus accumbens, Brain Res., 473 (1988) 398-400.
5. Crawley, J.N., Cholecystokinin modulates dopamine-mediated behaviors, Ann. N. Y. Acad. Sci., 713 (1994) 138-142.
6. Csernansky, J.G., Glick, S. and Mellentin, J., Differential effects of proglumide on mesolimbic and nirgrostriatal dopamine function, Psychopharmacology, 91 (1987) 440-444.
7. Cunningham, S.T. and Kelly, A.E., Opiate infusion in the nucleus accumbens: contrasting effects on motor activity and responding for conditioned reward, Brain Res., 588 (1992) 104-114.
8. Feifel, D., Minor, K.L., Dulawa, S. and Swerdlow, N.R., The effects of intra-accumbens neurotensin on sensorimotor gating, Brain Res., (1997) in press.
9. Mansbach, R.S., Geyer, M.A. and Braff, D.L., Dopaminergic stimulation disrupts sensorimotor gating in the rat, Psychopharmacology, 94 (1988) 507-514.
10. Pellegrino, L.J. and Cushman, A.J., A Stereotaxic Atlas of the Rat Brain, Plenum Press, New York, NY, 1979.
11. Rasmussen, K., Czachur, J.F., Stockton, M.E. and Howbert, J.J., Electrophysiological effects of cholecystokinin-B and cholecystokinin-A anatagonists on midbrain dopamine neurons, J. Pharmacol. Exp. Ther., 264 (1993) 480-488.
12. Robledo, P., Maldonado, R. and Koob, G.F., Neurotensin injected into the nucleus accumbens blocks the psychostimulant effects of cocaine but does not attenuate cocaine self-administration in the rat, Brain Res., 622 (1993) 105-112.
13. Schalling, M., Friberg, K. and Seroogy, K., Analysis of expression of cholecystokinin in dopamine cells in the ventral mesencephalon of several species and human with schizophrenia, Proc. Natl. Acad. Sci. USA, 87 (1990) 8427-8431.
14. Swerdlow, N.R., Caine, S.B., Braff, D.L. and Geyer, M.A., The neural substrates of sensorimotor gating of the startle reflex: a review of recent findings and their implications, J. Psychopharmacol., 6 (1992) 176-190.
15. Swerdlow, N.R., Braff, D.L., Taaid, N. and Geyer, M.A., Assessing the validity of an animal model of sensorimotor gating deficits in schizophrenia, Arch. Gen. Psychiatry, 51 (1994) 139-154.
16. Vaccarino, F.J., Nucleus accumbens dopamine-CCK interactions in psychostimulant reward and related behaviors, Neurosci. Biobehav. Rev., 18 (1994) 207-214.